I am an outcomes researcher and hematologic oncologist at Dana-Farber (DFCI). My research aims to apply health services methods to understand the experiences of patients with cancer, and to answer questions about the effectiveness of their care. I am also interested in evaluating how intensive cancer therapy affects quality of life and developing innovations to address disparities in care. I primarily focus on the hematologic malignancies, studying the impact of these diseases and their treatment from diagnosis to the end of life. I also help run DFCI’s Older Adult Hematologic Malignancy (OHM) geriatric research program, and serve as Co-Chair of the DFCI Ethics Advisory Committee.